Konventionelle Hormonersatztherapie (HRT) und Tibolon: Wirkung auf die Brust
Journal für Menopause 2003; 10 (Sonderheft 3) (Ausgabe für Österreich): 13-15
Volltext (PDF) Summary
Keywords: Brust, Estrogen, Hormonersatztherapie, HRT, Liviel, Mamma, Menopause, Organon GesmbH, Progestagen, Tibolon, Tumor
Preclinical studies show that estrogens can act as tumour promotors as well as tumour initiators. The role of progestagens is less clear. Tibolone does not stimulate the breast tissue in preclinical studies. In clinical studies, tibolone shows less breast stimulation than combined HRT does, as judged from breast density and mastalgia studies.
Journal für Menopause 2003; 10 (Sonderheft 3) (Ausgabe für Österreich): 13-15
Volltext (PDF) Summary
Keywords: Brust, Estrogen, Hormonersatztherapie, HRT, Liviel, Mamma, Menopause, Organon GesmbH, Progestagen, Tibolon, Tumor
Preclinical studies show that estrogens can act as tumour promotors as well as tumour initiators. The role of progestagens is less clear. Tibolone does not stimulate the breast tissue in preclinical studies. In clinical studies, tibolone shows less breast stimulation than combined HRT does, as judged from breast density and mastalgia studies.